C60 fullerene against SARS-CoV-2 coronavirus : an in silico insight

© 2021. The Author(s)..

Based on WHO reports the new SARS-CoV-2 coronavirus is currently widespread all over the world. So far > 162 million cases have been confirmed, including > 3 million deaths. Because of the pandemic still spreading across the globe the accomplishment of computational methods to find new potential mechanisms of virus inhibitions is necessary. According to the fact that C60 fullerene (a sphere-shaped molecule consisting of carbon) has shown inhibitory activity against various protein targets, here the analysis of the potential binding mechanism between SARS-CoV-2 proteins 3CLpro and RdRp with C60 fullerene was done; it has resulted in one and two possible binding mechanisms, respectively. In the case of 3CLpro, C60 fullerene interacts in the catalytic binding pocket. And for RdRp in the first model C60 fullerene blocks RNA synthesis pore and in the second one it prevents binding with Nsp8 co-factor (without this complex formation, RdRp can't perform its initial functions). Then the molecular dynamics simulation confirmed the stability of created complexes. The obtained results might be a basis for other computational studies of 3CLPro and RdRp potential inhibition ways as well as the potential usage of C60 fullerene in the fight against COVID-19 disease.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Scientific reports - 11(2021), 1 vom: 07. Sept., Seite 17748

Sprache:

Englisch

Beteiligte Personen:

Hurmach, Vasyl V [VerfasserIn]
Platonov, Maksim O [VerfasserIn]
Prylutska, Svitlana V [VerfasserIn]
Scharff, Peter [VerfasserIn]
Prylutskyy, Yuriy I [VerfasserIn]
Ritter, Uwe [VerfasserIn]

Links:

Volltext

Themen:

3C-like proteinase, SARS-CoV-2
Antiviral Agents
Coronavirus 3C Proteases
Coronavirus Protease Inhibitors
Coronavirus RNA-Dependent RNA Polymerase
EC 2.7.7.48
EC 3.4.22.-
EC 3.4.22.28
Fullerenes
Journal Article
NSP12 protein, SARS-CoV-2
Nucleic Acid Synthesis Inhibitors
RNA, Viral
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 14.09.2021

Date Revised 03.04.2024

published: Electronic

Citation Status MEDLINE

doi:

10.1038/s41598-021-97268-6

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM330360892